2016 Angola and DR Congo yellow fever outbreak

Last updated
2016 Angola and DR Congo yellow fever outbreak
2016 Angola and DR Congo yellow fever outbreak.png
As of 28 October 2016 [1]
Angola
  • 884 confirmed cases
  • 121 deaths among confirmed cases (case fatality rate, 13.7%)
  • 4347 suspected cases
  • 377 deaths among suspected cases (case fatality rate, 8.7%)
DR Congo
  • 78 confirmed cases (57 imported from Angola, 8 sylvatic, 13 autochthonous)
  • 16 deaths among confirmed cases (case fatality rate, 21.1%)
  • 2987 suspected cases
  • 121 deaths among suspected cases (case fatality rate, 4.0%)

( Sylvatic cases are not considered part of the outbreak.)

Contents

Kenya
  • 2 confirmed cases
China (not on map)
  • 11 confirmed cases
Yellow fever cases by age group in Angola, from 5 December 2015 to 4 August 2016. YFcasesbyagegroupAngola2016.png
Yellow fever cases by age group in Angola, from 5 December 2015 to 4 August 2016.
Confirmed cases and deaths (cumulative) in the 2016 epidemic of yellow fever in Angola as of 21 July 2016 Line graph of confirmed cases and deaths (cumulative) in the 2016 epidemic of yellow fever in Angola as of 21 July 2016.png
Confirmed cases and deaths (cumulative) in the 2016 epidemic of yellow fever in Angola as of 21 July 2016

On 20 January 2016, the health minister of Angola reported 23 cases of yellow fever with 7 deaths among Eritrean and Congolese citizens living in Angola in Viana municipality, a suburb of the capital of Luanda. The first cases (hemorrhagic fever suspected as being yellow fever) were reported in Eritrean visitors beginning on 5 December 2015 and confirmed by the Pasteur WHO reference laboratory in Dakar, Senegal in January. [4] [5] The outbreak was classified as an urban cycle of yellow fever transmission, which can spread rapidly. [6] A preliminary finding that the strain of the yellow fever virus was closely related to a strain identified in a 1971 outbreak in Angola was confirmed in August 2016. [7] Moderators from ProMED-mail stressed the importance of initiating a vaccination campaign immediately to prevent further spread. The CDC classified the outbreak as Watch Level 2 (Practice Enhanced Precautions) on 7 April 2016. [8] The WHO declared it a grade 2 event on its emergency response framework having moderate public health consequences. [9]

At an emergency committee meeting in Geneva, Switzerland on 19 May 2016, the WHO declared that the outbreak was serious and might continue to spread, but decided not to declare a public health emergency of international concern (PHEIC). [10] [11] On 30 May, Margaret Chan, director-general of WHO published a commentary on the bold action needed to prevent further spread of this important communicable disease that caused many historically significant epidemics that took many lives in previous centuries. [12] On 8 June the International Federation of Red Cross and Red Crescent Societies called for a scale-up in the response because of the lack of vaccine and other limitations amid the continuing spread of the outbreak. [13] On 12 August 2016, Daniel R. Lucey, a ProMED mail consultant, wrote an open letter to Dr. Chan requesting that the WHO emergency committee be reconvened to consider a PHEIC because of the continued spread of the disease in Democratic Republic of the Congo, the lack of sufficient vaccine, and concern that it may be spreading into the Republic of the Congo. [14] On 31 August, the decision to not declare a PHEIC was re-confirmed. [15] By 2 September 2016, WHO announced there had been no new cases in either Angola or DR Congo in over a month due to a massive vaccination campaign. [16] On 25 November 2016, WHO announced that four months had passed without a new case. The last case in Angola was on 23 June and the last case in DR Congo was on 12 July. Dr Matshidiso Moeti, WHO Regional Director for Africa, stated: "The current battle against yellow fever in Angola and the Democratic Republic of the Congo is coming to a close, ... But the broader war against the disease is just getting started." [17] ProMED-mail moderator Tom Yuill noted that maintaining vaccination coverage in the two countries will be the next challenge. Approximately 30 million people were vaccinated in the two countries. [18]

Spread within Angola

By early February, suspected cases were being reported from southern Huila province, about a 1000 kilometers south, and the provinces of Bié, Benguela, Cunene, Cabinda, Hula, Huambo, Malange, Kwanza Sul, Uige, Zaire and Kwanza Norte. [19] As of 9 March 2016, the WHO reported that there were 65 confirmed cases, 813 suspected cases, and 138 deaths in Angola. [20] On 22 March, WHO reported that cases had occurred in 6 of the 18 provinces of Angola, and that transmission was ongoing. Suspected and confirmed cases totaled 1,132, with 375 cases laboratory confirmed and 168 deaths. [21] [22] The situation report of 28 October 2016 reported the most recent number of suspected cases and laboratory-confirmed cases; total deaths and case fatality rates, with suspected and confirmed cases. [23] Local, or autochthonous, transmission had been reported in 12 provinces as of 28 October. Confirmed cases had been reported in 16 of 18 provinces. No new cases were reported during July. [24] The WHO congratulated the Angolan government on its effort to contain the outbreak. [25]

Spread to neighboring African countries

On 22 March 2016, the WHO was notified of 21 deaths from yellow fever in the Democratic Republic of the Congo, some in a province that borders Angola. [26] As of 31 May, 700 suspected cases and 63 deaths had been reported to WHO through the national surveillance system. [27] As of 31 May, 52 cases were laboratory confirmed by the National Institute for Biomedical Research in Kinshasa and the Pasteur Institute in Dakar. Forty-six of the 52 cases were imported from Angola; 2 were classified as autochthonous. Local transmission was still ongoing in urban areas in Angola and DR Congo. WHO classified the outbreak in DR Congo as a Grade 2 Emergency. On 30 May, the GAVI Alliance announced the launch of a mass vaccination campaign in DR Congo, [28] but as of 22 June, vaccine was in short supply. [29] On 20 June, the health minister declared the outbreak of yellow fever in three provinces, including the capital of DR Congo, Kinshasa. [30] Transmission within Kinshasa is of concern because of the large and densely packed population. As of 8 July, WHO was notified of 1798 suspected cases, with 68 confirmed cases (59 imported from Angola) and 85 deaths. [31] In the WHO situation report of 23 September, the last confirmed non-sylvatic or urban case had symptom onset on 12 July. [32]

On 17 March, two cases, including one death, were reported in Kenya, imported from Angola. [33] On 28 March, a rapid response team was deployed into Uganda, where there was ongoing transmission unrelated to the Angola outbreak. [34] According to WHO, cases had been exported from Angola to China, DR Congo, and Kenya, as of 4 May 2016. One case had been reported in Namibia. [35]

ProMED mail reported that as of 3 Aug 2016, 193 cases of yellow fever were suspected in the Republic of the Congo, with 4 cases having tested positive for yellow fever IgM. [36]

Spread to China via air travel

On 13 March 2016, the Chinese government confirmed that a 32-year-old male Chinese citizen who had been in Angola had developed yellow fever on return. [37] [38] The case was the first imported yellow fever case in China in history. Yellow fever has never appeared in Asia even though the mosquito vector is present. [39] [40] Additional cases were later reported in people who first had symptoms while in Luanda. [41] ProMED-mail moderator Jack Woodall warned that "spread could make the Ebola and Zika epidemics look like picnics in the park!" and that "international action should start now." [42] Chinese authorities strengthened thermal imaging at airports to detect passengers with elevated body temperatures. [43] A Chinese medical team deployed to Angola vaccinated 120 Chinese nationals as part of epidemic research. [44] More than 250,000 Chinese nationals live in Angola. On 8 April 2016, ten North Korean workers in Angola were reported to have died of yellow fever. [45]

On 25 March 2016, a case was reported in Fujian Province, in a woman who returned from Angola on 12 March. [46] Fujian is within the predicted distribution of Aedes aegypti, the mosquito that transmits the yellow fever virus to humans. Mosquito-borne diseases can become endemic in a new geographic area when local mosquitoes become infected by feeding on an imported case. [47] Between 18 March and 22 April, the WHO was notified of 11 imported cases in China. [48] Officials in Asia were concerned about the threat of yellow fever. [49]

In June 2016, the genetic sequence of a virus from a yellow fever infected Chinese traveler to Angola was posted to GenBank by the Chinese CDC. [50] The strain closely matched a 1971 strain, indicating that the yellow fever virus may have been circulating in the region for at least 45 years. The finding was consistent with earlier phylogenetic analyses performed during the outbreak. [51]

Potential for further international spread

On 28 March, ProMED-mail moderators Jack Woodall and Tom Yuill issued a strongly worded warning on the threat of yellow fever for countries that have endemic dengue fever (and thus the mosquito vector of yellow fever and dengue fever, Aedes aegypti), and particularly for countries in Asia, where until recently yellow fever has never appeared. Urban populations and mosquito-infested slums in Asia and Africa are much larger than in the past. [52] A commentary and accompanying article published in May stressed the potential for spread to Asia by international air travel. [53] [54] Other parts of the world where yellow fever is present but usually in the quiescent jungle cycle, and where there is regular air travel, such as Brazil, may also be vulnerable. [55] They stressed that world stocks of 7 million doses of vaccine have been exhausted in the vaccination campaign against the outbreak in Angola. If yellow fever spread to the 18 countries in Asia where the mosquito vector is present, more than 2 billion people would be at risk. They stated: "Apocalyptic forecasts of the numbers of fatalities from Ebola turned out to be wildly wrong, and we can hope that will again be the case here, but given the way Zika has exploded in the Western hemisphere, we can't count on it." [56] CDC said they could not assist as much in the outbreak because all its experts were involved in efforts against the Zika virus outbreak in the Americas. [57] Starting on 26 April, ProMED-mail issued a series of posts on pre-planning information for countries at risk of importation of yellow fever, covering vaccination, mosquito control, quarantine and personal protection measures. [58] [59]

In an article in JAMA on 9 May 2016, the Georgetown University Law Center called for the WHO to form an emergency committee to determine whether a public health emergency of international concern should be declared. [60] On 12 May, the European Commissioner for Humanitarian Aid and Civil Protection of the European Union announced plans to send a team of the European Medical Corps to Angola on a two-week mission to help control the outbreak and assess the risk of further spread outside Angola. [61] The medical corps was formed after the Ebola outbreak in West Africa that began in 2013, and the mission to Angola was its first deployment. The team included "emergency medical teams, public health and medical coordination experts, mobile biosafety laboratories, medical evacuation planes and logistical support teams". [62] [63]

Efforts to prevent international spread are confounded by the practice of selling falsified yellow fever vaccination certificates. [64] The fake cards are sold to people who are required to have proof of vaccination after travel to areas where yellow fever is endemic. On 11 February 2016, the Pasteur Institute (WHO) in Senegal warned of fake yellow fever vaccine on the international market. [65]

Vaccination campaign

With help from the World Health Organization (WHO), the Angolan Ministry of Health began a campaign of preventive measures including vector control and vaccination in Viana in the first week of February. [66] However, the minister reported that the government had enough vaccine for routine vaccination, but not enough to contain an outbreak. [67] The WHO was supporting the Angolan government in immunization of 6.7 million people in Luanda province with the aim of vaccinating at least 80% of the population at risk of infection. [68] The vaccine supply began to run low by late March, with the director of the CDC, Tom Friedman, warning that "It's possible we could run out of vaccine." [69] The goal of the vaccination campaign in Luanda province was to vaccinate 88 percent of the population (5 804 475 of 6 583 216); ProMED reported that the total national stock of yellow fever vaccine as of 29 Mar 2016 was 1 032 970 doses. [70] As of 10 April 2016, almost 6 million people had been vaccinated in Luanda. [71] On 19 April, the WHO reported that the campaign had been extended into the provinces of Huambo and Benguela where local transmission was reported. [72] On 23 May, the WHO reported that 7.8 million people (91.1%) had been vaccinated in the three provinces. [73] On 23 May, the WHO announced that coverage of an additional 2.7 million people in 5 provinces had reached 55% after 6 days of vaccination. [74]

If the epidemic were to spread, particularly into Asia, the global supply of vaccine would have been insufficient to protect the millions of people that would need to be vaccinated to curb an epidemic. [75] As an emergency measure, experts suggested the dose-sparing strategy to extend existing supplies of vaccine, which the WHO could provide under the Emergency Use Assessment and Listing procedure. [76] The WHO agreed to the recommendation in June 2016, authorizing one-fifth the usual dose during the ongoing outbreak in Angola and DR Congo, but international health regulations still apply to travelers, who must obtain the full dose to quality for the certificate of vaccination. [77]

On June 22, the WHO announced plans to launch a pre-emptive emergency vaccination campaign beginning in July in highly trafficked borders areas of Angola and DR Congo and in densely populated Kinshasa. [78] On 20 July, the DR Congo government launched a campaign to deliver 1 million doses of yellow fever vaccine over 10 days. [79] In August, the WHO with partners including Médecins sans Frontières, International Federation of the Red Cross and UNICEF launched another campaign to vaccinate more than 14 million people in Angola and DR Congo. [80] On 2 September, WHO announced that the campaign to vaccinate the 7.7 million residents of Kinshasa, the capital of DR Congo, had been completed in record time and before the beginning of the rainy season in September when the mosquito population expands. [81] The campaign required 10 million specialized syringes and training of 40,000 vaccinators, using the dose sparing strategy of 1/5 the usual dose. Later studies found that the one-fifth-dose vaccine was just as protective as the full dose, even 10 years after the vaccination. [82]

In August it was reported that of the 6 million vaccine doses shipped by WHO to Angola in February, one million doses went missing, resulting in shortages to fight the spreading epidemic in DR Congo. [83] Vaccine and syringes might have been diverted for sale in private markets. [84]

In the situation report of 23 September, the WHO announced a second phase of the vaccination campaign in Angola and a planned pre-emptive vaccination campaign for the Republic of Congo. [85]

Response to the epidemic

In June 2016, a WHO representative in Luanda said that the initial investigation of the outbreak was thrown off course because the first cases in December 2015—the sick Eritrean visitors—had what were later identified as fake yellow fever vaccination certificates. All had been to the same restaurant, so food poisoning was initially suspected as the cause of the mystery illness. [86] It was more than a month before blood samples from the Eritreans reached the Pasteur Institute lab and yellow fever was recognized. Public health experts identified that as one factor that delayed the response to the outbreak, which came close to being a much larger disaster, if vaccine supplies had not been successfully raised in time, or the disease had spread to other countries and continents. [87] The concurrent Zika outbreak drew attention away from a potentially far more serious epidemic of yellow fever. [88]

Related Research Articles

<span class="mw-page-title-main">Yellow fever</span> Viral disease

Yellow fever is a viral disease of typically short duration. In most cases, symptoms include fever, chills, loss of appetite, nausea, muscle pains—particularly in the back—and headaches. Symptoms typically improve within five days. In about 15% of people, within a day of improving the fever comes back, abdominal pain occurs, and liver damage begins causing yellow skin. If this occurs, the risk of bleeding and kidney problems is increased.

<span class="mw-page-title-main">Measles</span> Viral disease affecting humans

Measles is a highly contagious, vaccine-preventable infectious disease caused by measles virus. Symptoms usually develop 10–12 days after exposure to an infected person and last 7–10 days. Initial symptoms typically include fever, often greater than 40 °C (104 °F), cough, runny nose, and inflamed eyes. Small white spots known as Koplik's spots may form inside the mouth two or three days after the start of symptoms. A red, flat rash which usually starts on the face and then spreads to the rest of the body typically begins three to five days after the start of symptoms. Common complications include diarrhea, middle ear infection (7%), and pneumonia (6%). These occur in part due to measles-induced immunosuppression. Less commonly seizures, blindness, or inflammation of the brain may occur. Other names include morbilli, rubeola, red measles, and English measles. Both rubella, also known as German measles, and roseola are different diseases caused by unrelated viruses.

<span class="mw-page-title-main">Polio vaccine</span> Vaccine to prevent poliomyelitis

Polio vaccines are vaccines used to prevent poliomyelitis (polio). Two types are used: an inactivated poliovirus given by injection (IPV) and a weakened poliovirus given by mouth (OPV). The World Health Organization (WHO) recommends all children be fully vaccinated against polio. The two vaccines have eliminated polio from most of the world, and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 33 in 2018.

<span class="mw-page-title-main">Mpox</span> Viral disease of humans and animals

Mpox is an infectious viral disease that can occur in humans and other animals. Symptoms include a rash that forms blisters and then crusts over, fever, and swollen lymph nodes. The illness is usually mild and most of those infected will recover within a few weeks without treatment. The time from exposure to onset of symptoms ranges from five to twenty-one days and symptoms typically last from two to four weeks. Cases may be severe, especially in children, pregnant women or people with suppressed immune systems.

<span class="mw-page-title-main">Disease surveillance</span> Monitoring spread of disease to establish patterns of progression

Disease surveillance is an epidemiological practice by which the spread of disease is monitored in order to establish patterns of progression. The main role of disease surveillance is to predict, observe, and minimize the harm caused by outbreak, epidemic, and pandemic situations, as well as increase knowledge about which factors contribute to such circumstances. A key part of modern disease surveillance is the practice of disease case reporting.

<span class="mw-page-title-main">Polio eradication</span> Effort to permanently eliminate all cases of poliomyelitis infection

Polio eradication, the permanent global cessation of circulation of the poliovirus and hence elimination of the poliomyelitis (polio) it causes, is the aim of a multinational public health effort begun in 1988, led by the World Health Organization (WHO), the United Nations Children's Fund (UNICEF) and the Rotary Foundation. These organizations, along with the U.S. Centers for Disease Control and Prevention (CDC) and The Gates Foundation, have spearheaded the campaign through the Global Polio Eradication Initiative (GPEI). Successful eradication of infectious diseases has been achieved twice before, with smallpox in humans and rinderpest in ruminants.

<span class="mw-page-title-main">ProMED-mail</span> Emerging diseases and outbreak reporting system

Program for Monitoring Emerging Diseases is among the largest publicly available emerging diseases and outbreak reporting systems in the world. The purpose of ProMED is to promote communication amongst the international infectious disease community, including scientists, physicians, veterinarians, epidemiologists, public health professionals, and others interested in infectious diseases on a global scale. Founded in 1994, ProMED has pioneered the concept of electronic, Internet-based emerging disease and outbreak detection reporting. In 1999, ProMED became a program of the International Society for Infectious Diseases. As of 2016, ProMED has more than 75,000 subscribers in over 185 countries. With an average of 13 posts per day, ProMED provides users with up-to-date information concerning infectious disease outbreaks on a global scale.

<span class="mw-page-title-main">Measles vaccine</span> Vaccine used to prevent measles

Measles vaccine protects against becoming infected with measles. Nearly all of those who do not develop immunity after a single dose develop it after a second dose. When the rate of vaccination within a population is greater than 92%, outbreaks of measles typically no longer occur; however, they may occur again if the rate of vaccination decreases. The vaccine's effectiveness lasts many years. It is unclear if it becomes less effective over time. The vaccine may also protect against measles if given within a couple of days after exposure to measles.

<span class="mw-page-title-main">Yellow fever vaccine</span> Vaccine that protects against yellow fever

Yellow fever vaccine is a vaccine that protects against yellow fever. Yellow fever is a viral infection that occurs in Africa and South America. Most people begin to develop immunity within ten days of vaccination and 99% are protected within one month, and this appears to be lifelong. The vaccine can be used to control outbreaks of disease. It is given either by injection into a muscle or just under the skin.

rVSV-ZEBOV vaccine Vaccine against Ebola virus disease

Recombinant vesicular stomatitis virus–Zaire Ebola virus (rVSV-ZEBOV), also known as Ebola Zaire vaccine live and sold under the brand name Ervebo, is an Ebola vaccine for adults that prevents Ebola caused by the Zaire ebolavirus. When used in ring vaccination, rVSV-ZEBOV has shown a high level of protection. Around half the people given the vaccine have mild to moderate adverse effects that include headache, fatigue, and muscle pain.

In late 2012, a yellow fever outbreak occurred in the Darfur region of Sudan that was the largest yellow fever epidemic to strike Africa in two decades. On 10 January 2013, the Sudan Federal Ministry of Health and the World Health Organization (WHO) reported that there had been 847 suspected cases since 2 September 2012, including 171 deaths, for an estimated case fatality rate of 20%. A mass vaccination campaign was launched in mid-November. By early January, the five states of Darfur were free of any new cases.

<span class="mw-page-title-main">John P. Woodall</span> American entomologist

John Payne Woodall (1935–2016), known as Jack Woodall, was an American-British entomologist and virologist who made significant contributions to the study of arboviruses in South America, the Caribbean and Africa. He did research on the causative agents of dengue fever, Crimean–Congo hemorrhagic fever, o'nyong'nyong fever, yellow fever, Zika fever, and others.

Dr. Robert Kezaala is a medical doctor, epidemiologist, scholar and public health leader in the field of immunization and health emergencies. Currently he is serving as a Senior Health Advisor and team lead for Accelerated Immunization Initiatives: measles, rubella, epidemic meningitis and yellow fever control and Immunization in Emergencies at the United Nations Children’s Fund.

<span class="mw-page-title-main">2017 Democratic Republic of the Congo Ebola outbreak</span> Disease outbreak in the Democratic Republic of the Congo

On 11 May 2017, the Democratic Republic of the Congo (DRC) was identified by the World Health Organization (WHO) as having one Ebola-related death.

<span class="mw-page-title-main">2018 Équateur province Ebola outbreak</span> Disease outbreak in the Democratic Republic of the Congo

The 2018 Équateur province Ebola outbreak occurred in the north-west of the Democratic Republic of the Congo (DRC) from May to July 2018. It was contained entirely within Équateur province, and was the first time that vaccination with the rVSV-ZEBOV Ebola vaccine had been attempted in the early stages of an Ebola outbreak, with a total of 3,481 people vaccinated. It was the ninth recorded Ebola outbreak in the DRC.

<span class="mw-page-title-main">Kivu Ebola epidemic</span> Ebola virus outbreak in the eastern DRC from 2018 to 2020

The Kivu Ebola epidemic was an outbreak of Ebola virus disease (EVD) mainly in eastern Democratic Republic of the Congo (DRC), and in other parts of Central Africa, from 2018 to 2020. Between 1 August 2018 and 25 June 2020 it resulted in 3,470 reported cases. The Kivu outbreak also affected Ituri Province, whose first case was confirmed on 13 August 2018. In November 2018, the outbreak became the biggest Ebola outbreak in the DRC's history, and had become the second-largest Ebola outbreak in recorded history worldwide, behind only the 2013–2016 Western Africa epidemic. In June 2019, the virus reached Uganda, having infected a 5-year-old Congolese boy who entered Uganda with his family, but was contained.

Dr. Daniel R. Lucey is an American physician, researcher, clinical professor of medicine of infectious diseases at Geisel School of Medicine at Dartmouth, and a research associate in anthropology at the Smithsonian National Museum of Natural History, where he has co-organised an exhibition on eight viral outbreaks.

<span class="mw-page-title-main">COVID-19 pandemic in Benin</span>

The COVID-19 pandemic in Benin was a part of the ongoing worldwide pandemic of coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2. The virus was confirmed to have reached Benin in March 2020.

Fractional dose vaccination is a strategy to reduce the dose of a vaccine to achieve a vaccination policy goal that is more difficult to achieve with conventional vaccination approaches, including deploying a vaccine faster in a pandemic, reaching more individuals in the setting of limited healthcare budgets, or minimizing side effects due to the vaccine.

References

  1. ↑ "Yellow fever situation report 28 October 2016". World Health Organization. Archived from the original on December 19, 2016. Retrieved 8 December 2016.
  2. ↑ "Situation Report: Yellow fever outbreak in Angola, 5 August 2016". Archived from the original on 15 August 2016. Retrieved 15 August 2016.
  3. ↑ "Yellow fever situation report 21 July 2016". World Health Organization. Archived from the original on July 22, 2016. Retrieved 23 July 2016.
  4. ↑ "Situation report: Yellow fever outbreak in Angola, 14 March 2016". www.afro.who.int. Archived from the original on 7 April 2016. Retrieved 5 April 2016.
  5. ↑ "Yellow fever - Africa (16): Angola 2016-02-27 10:11:59 Archive Number: 20160227.4053826". Pro-MED-mail. International Society for Infectious Diseases. Retrieved 17 March 2016.
  6. ↑ "Yellow fever - Africa (18): Angola". Pro-MED-mail. International Society for Infectious Diseases. Retrieved 15 April 2016.
  7. ↑ Grobbelaar, AA; Weyer, J; Moolla, N; Jansen van Vuren, P; Moises, F; Paweska, JT (15 October 2016). "Resurgence of Yellow Fever in Angola, 2015-2016". Emerging Infectious Diseases. 22 (10): 1854–1855. doi:10.3201/eid2210.160818. PMC   5038398 . PMID   27536787.
  8. ↑ "Yellow Fever in Angola". Traveler's Health. Centers for Disease Control and Prevention. Retrieved 8 April 2016.
  9. ↑ "Yellow fever - Africa (40): Angola, WHO". Pro-MED-mail. International Society for Infectious Diseases. Retrieved 15 April 2016.
  10. ↑ "Meeting of the Emergency Committee under the International Health Regulations (2005) concerning Yellow Fever". World Health Organization. Archived from the original on May 20, 2016. Retrieved 19 May 2016.
  11. ↑ McNeil, Donald G. Jr. (19 May 2016). "W.H.O. Calls Yellow Fever in Africa 'Serious Concern'". The New York Times. Retrieved 19 May 2016.
  12. ↑ Chan, Margaret (2016). "Yellow fever: the resurgence of a forgotten disease". Lancet. 387 (10034): 2165–6. doi:10.1016/S0140-6736(16)30620-1. PMID   27229187. S2CID   41390168. Archived from the original on May 31, 2016. Retrieved 4 June 2016.
  13. ↑ "Red Cross calls for immediate scale-up in response to deadly yellow fever outbreak in Angola - IFRC". www.ifrc.org. Retrieved 12 June 2016.
  14. ↑ "Yellow fever - Africa (92): WHO, Angola, Congo DR, letter to WHO". www.promedmail.org. International Society for Infectious Diseases. Retrieved 15 August 2016.
  15. ↑ "Second meeting of the Emergency Committee under the International Health Regulations (2005) concerning yellow fever". World Health Organization. Retrieved 1 September 2016.
  16. ↑ "Millions protected in Africa's largest-ever emergency yellow fever vaccination campaign". World Health Organization. 2 September 2016. Retrieved 3 September 2016.
  17. ↑ "Winning the war against yellow fever". World Health Organization. Retrieved 28 November 2016.
  18. ↑ "Yellow fever - Africa (110): Angola, Congo DR, WHO". www.promedmail.org. International Society for Infectious Diseases. Retrieved 28 November 2016.
  19. ↑ "Yellow fever - Africa (16): Angola 2016-02-27 10:11:59 Archive Number: 20160227.4053826". Pro-MED-mail. International Society for Infectious Diseases. Retrieved 17 March 2016.
  20. ↑ "Angola immunizes 6.7 million people against yellow fever". WHO Regional Office for Africa. World Health Organization. Archived from the original on March 18, 2016. Retrieved 17 March 2016.
  21. ↑ "Yellow Fever – Angola". Emergencies preparedness, response. World Health Organization. Archived from the original on March 26, 2016. Retrieved 23 March 2016.
  22. ↑ "Angola grapples with worst yellow fever outbreak in 30 years". World Health Organization. Retrieved 25 March 2016.
  23. ↑ "Yellow fever situation report". World Health Organization. Archived from the original on December 19, 2016. Retrieved 17 December 2016.
  24. ↑ "Yellow fever - Africa (92): WHO, Angola, Congo DR, letter to WHO". www.promedmail.org. International Society for Infectious Diseases. Retrieved 15 August 2016.
  25. ↑ "Angola: WHO Congratulates Angola On Its Commitment to Yellow Fever Control". Allafrica. 17 July 2016. Retrieved 17 July 2016.
  26. ↑ "Congo Records 21 Yellow Fever Deaths". CTV News. Associated Press. 12 April 2016. Retrieved 6 April 2020.
  27. ↑ "Yellow fever – Democratic Republic of the Congo". World Health Organization. Archived from the original on June 3, 2016. Retrieved 4 June 2016.
  28. ↑ "Yellow fever - Africa (59): DR Congo, vaccination". www.promedmail.org. International Society for Infectious Diseases.
  29. ↑ "Congo almost runs out of yellow fever vaccine amid epidemic". news.trust.org. Retrieved 30 June 2016.
  30. ↑ "A yellow fever epidemic has broken out in the Congo". Business Insider. Retrieved 22 June 2016.
  31. ↑ "Yellow fever situation report 15 July 2016". World Health Organization. Archived from the original on July 16, 2016. Retrieved 17 July 2016.
  32. ↑ "Yellow fever situation report 23 September 2016". World Health Organization. Archived from the original on September 24, 2016. Retrieved 25 September 2016.
  33. ↑ "Yellow fever - Africa (24): Kenya ex Angola 2016-03-18 18:40:36". ProMED-mail. International Society for Infectious Diseases. Retrieved 17 March 2016.
  34. ↑ "Yellow fever – Uganda - WHO | Regional Office for Africa". www.afro.who.int. Archived from the original on 8 May 2016. Retrieved 8 May 2016.
  35. ↑ "Yellow fever". World Health Organization. Archived from the original on May 1, 2016. Retrieved 8 May 2016.
  36. ↑ "Yellow fever - Africa (92): WHO, Angola, Congo DR, letter to WHO". www.promedmail.org. International Society for Infectious Diseases. Retrieved 15 August 2016.
  37. ↑ "Yellow fever - China: ex Angola, 1st case in Asia 2016-03-13 16:14:53". ProMED-mail. International Society for Infectious Diseases. Retrieved 19 March 2016.
  38. ↑ "Yellow Fever – China". World Health Organization. Archived from the original on April 2, 2016. Retrieved 30 March 2016.
  39. ↑ Wilder-Smith, A.; Massad, E. (17 April 2018). "Estimating the number of unvaccinated Chinese workers against yellow fever in Angola". BMC Infectious Diseases. 18 (1): 185. doi: 10.1186/s12879-018-3084-y . ISSN   1471-2334. PMC   5905133 . PMID   29665797.
  40. ↑ Vainio, J; Cutts, F (1998). Yellow Fever. World Health Organization. hdl:10665/64455.
  41. ↑ "Yellow fever - China (03): ex Angola 2016-03-19 22:06:08 20160319.4106312". ProMED-mail. International Society for Infectious Diseases. Retrieved 19 March 2016.
  42. ↑ "Yellow fever - China: ex Angola, 1st case in Asia 2016-03-13 16:14:53". ProMED-mail. International Society for Infectious Diseases. Retrieved 17 March 2016.
  43. ↑ "Guangdong strengthens monitoring of body temperature on passengers (2)". Xinhua/Liu Dawei. 16 February 2016. Retrieved 20 March 2016.
  44. ↑ "Yellow fever - Africa (32): Angola 2016-03-29 20:31:42 Archive Number". International Society for Infectious Diseases. Retrieved 30 March 2016.
  45. ↑ Herald, The Korea (8 April 2016). "N. Korean workers die of yellow fever in Angola: RFA". www.koreaherald.com. Retrieved 10 April 2016.
  46. ↑ "Yellow fever - China (05) ex Angola 2016-03-25 17:56:49 Archive Number: Archive Number: 20160325.4119422". ProMED-mail. International Society for Infectious Diseases. Retrieved 17 March 2016.
  47. ↑ Hennessey, Morgan; Fischer, Marc; Staples, J. Erin (2016). "Zika Virus Spreads to New Areas — Region of the Americas, May 2015–January 2016". MMWR. Morbidity and Mortality Weekly Report. 65 (3). Centers for Disease Control and Prevention: 1–4. doi:10.15585/mmwr.mm6503e1er. PMID   26820163 . Retrieved 26 March 2016.
  48. ↑ "Yellow Fever – China". World Health Organization. Archived from the original on April 23, 2016. Retrieved 1 May 2016.
  49. ↑ "Yellow Fever: Southeast Asia's next great outbreak? | GovInsider". 4 July 2016. Retrieved 4 July 2016.
  50. ↑ "Yellow fever virus in Angola". Virological. 2016-06-13. Retrieved 2020-01-12.
  51. ↑ Grobbelaar, Antoinette A.; Weyer, Jacqueline; Moolla, Naazneen; Vuren, Petrus Jansen van; Moises, Francisco; Pawęska, Janusz T. (2016). "Resurgence of Yellow Fever in Angola, 2015–2016". Emerging Infectious Diseases. 22 (10): 1854–5. doi:10.3201/eid2210.160818. PMC   5038398 . PMID   27536787.
  52. ↑ Butler, Declan (14 April 2016). "Fears rise over yellow fever's next move". Nature. 532 (7598): 155–156. Bibcode:2016Natur.532..155B. doi: 10.1038/532155a . PMID   27075072.
  53. ↑ Woodall, J.P.; Yuill, T.M. (2016). "Why is the yellow fever outbreak in Angola a 'threat to the entire world'?". International Journal of Infectious Diseases. 48: 96–97. doi: 10.1016/j.ijid.2016.05.001 . ISSN   1201-9712. PMID   27163382.
  54. ↑ Wasserman, Sean; Tambyah, Paul Anantharajah; Lim, Poh Lian (2016). "Yellow fever cases in Asia: primed for an epidemic". International Journal of Infectious Diseases. 48: 98–103. doi: 10.1016/j.ijid.2016.04.025 . hdl: 10220/47081 . ISSN   1201-9712. PMID   27156836.
  55. ↑ "Opinion: Who's Afraid of Yellow Fever? Why We Should Be". The Rio Times. 22 April 2016. Retrieved 24 April 2016.
  56. ↑ "Yellow fever - countries with dengue: alert 2016-03-28 20:39:56 Archive Number: Archive Number: 20160328.4123983". ProMED-mail. International Society for Infectious Diseases. Retrieved 29 March 2016.
  57. ↑ McNeil, Donald G. Jr. (4 April 2016). "Yellow Fever Outbreak in Angola Strains Health Organizations". The New York Times. Retrieved 7 April 2016.
  58. ↑ "Yellow fever - pre-planning for at-risk countries: vaccine". www.promedmail.org. International Society for Infectious Diseases. Retrieved 26 April 2016.
  59. ↑ "Yellow fever - pre-planning for at-risk countries (02): mosquito control". www.promedmail.org. International Society for Infectious Diseases. Retrieved 27 April 2016.
  60. ↑ Lucey, Daniel; Gostin, Lawrence O. (9 May 2016). "A yellow fever epidemic: A new global health emergency?". JAMA. 315 (24): 2661–2. doi:10.1001/jama.2016.6606. PMID   27158803.
  61. ↑ "EU sends new medical corps team to Angola yellow fever outbreak". EurActiv.com. 12 May 2016. Retrieved 13 May 2016.
  62. ↑ "European Commission - PRESS RELEASES - Press release - EU launches new European Medical Corps to respond faster to emergencies". europa.eu. Retrieved 13 May 2016.
  63. ↑ "Mobile labs deliver faster yellow fever test results". World Health Organization. Retrieved 15 August 2016.
  64. ↑ "Yellow fever - Africa (06): Nigeria, fake cards". ProMED-mail. International Society for Infectious Diseases. Retrieved 17 March 2016.
  65. ↑ "Yellow fever - Africa (15): Angola, fake vaccine, SE Asia, WHO alert 2016-02-24 13:32:43 Archive Number: 20160224.4047041". Pro-MED-mail. International Society for Infectious Diseases. Retrieved 17 March 2016.
  66. ↑ "Yellow fever - Africa (09): Angola 2016-02-08 09:32:03 Archive Number 20160208.4003005". ProMED-mail. International Society for Infectious Diseases. Retrieved 17 March 2016.
  67. ↑ "Yellow fever - Africa (07): Angola (LU) RFI 2016-02-01 14:32:42 Archive Number: 20160201.3984228". Pro-MED-mail. International Society for Infectious Diseases. Retrieved 17 March 2016.
  68. ↑ "Angola immunizes 6.7 million people against yellow fever". WHO Regional Office for Africa. World Health Organization. Archived from the original on March 18, 2016. Retrieved 17 March 2016.
  69. ↑ "Yellow fever vaccine shortage as outbreak in Angola spreads". CNN. 25 March 2016. Retrieved 29 March 2016.
  70. ↑ "Yellow fever - Africa (34): Angola, WHO 2016-04-04 12:10:59 09:32:03 Archive Number 20160404.4137096". ProMED-mail. International Society for Infectious Diseases. Retrieved 5 April 2016.
  71. ↑ "Situation Report: Yellow fever outbreak in Angola, 10 April 2016". www.afro.who.int. Archived from the original on 15 April 2016. Retrieved 15 April 2016.
  72. ↑ "Angola extends yellow fever vaccination campaign to Huambo and Benguela provinces". www.afro.who.int. Archived from the original on April 20, 2016. Retrieved 21 April 2016.
  73. ↑ "Situation Report: Yellow fever outbreak in Angola, 23 May 2016". www.afro.who.int. Archived from the original on 17 June 2016. Retrieved 28 May 2016.
  74. ↑ "Situation Report: Yellow fever outbreak in Angola, 23 May 2016". www.afro.who.int. Archived from the original on 17 June 2016. Retrieved 28 May 2016.
  75. ↑ Merelli, Annalisa (4 November 2015). "The world was running short of yellow fever vaccines—and millions were at risk". Quartz. Retrieved 17 April 2016.
  76. ↑ Monath, Thomas P; Woodall, Jack P; Gubler, Duane J; Yuill, Thomas M; Mackenzie, John S; Martins, Reinaldo M; Reiter, Paul; Heymann, David L (2016). "Yellow fever vaccine supply: a possible solution". The Lancet. 387 (10028): 1599–1600. doi:10.1016/S0140-6736(16)30195-7. PMID   27116054. S2CID   13106004.
  77. ↑ "Lower doses of yellow fever vaccine could be used in emergencies". World Health Organization. Retrieved 19 June 2016.
  78. ↑ "Launch of emergency vaccination campaigns on the DR Congo and Angola border". Archived from the original on June 24, 2016. Retrieved 25 June 2016.
  79. ↑ "Democratic Republic of Congo launches yellow fever vaccination drive". Reuters. 20 July 2016. Retrieved 21 July 2016.
  80. ↑ "Mass vaccination campaign to protect millions against yellow fever in Angola and Democratic Republic of the Congo". World Health Organization. Retrieved 20 August 2016.
  81. ↑ "Millions protected in Africa's largest-ever emergency yellow fever vaccination campaign". World Health Organization. 2 September 2016. Retrieved 3 September 2016.
  82. ↑ Soucheray, Stephanie (2018-11-26). "Study affirms fractional dosing with yellow fever vaccine". CIDRAP News. Retrieved 2022-06-08.
  83. ↑ "UN bungles response to Africa's yellow fever outbreak". 2016-08-05. Archived from the original on 6 August 2016. Retrieved 5 August 2016.
  84. ↑ Times, Los Angeles (2016-08-04). "Amid worst yellow fever outbreak in decades, 1 million vaccines go missing". Los Angeles Times. Archived from the original on 2021-10-06. Retrieved 15 August 2016.
  85. ↑ "Yellow fever situation report 23 September 2016". World Health Organization. Archived from the original on September 24, 2016. Retrieved 25 September 2016.
  86. ↑ Times, Los Angeles (18 May 2016). "Yellow fever outbreak: Health officials to weigh declaring global emergency". Los Angeles Times . Retrieved 12 June 2016.
  87. ↑ Calisher, CH; Woodall, JP (October 2016). "Yellow Fever-More a Policy and Planning Problem than a Biological One". Emerging Infectious Diseases. 22 (10): 1859–60. doi:10.3201/eid2210.160875. PMC   5038394 . PMID   27479749.
  88. ↑ McNeil, Donald G. Jr. (5 December 2016). "Yellow Fever Epidemic in Africa Shows Gaps in Vaccine Pipeline". The New York Times. Retrieved 7 December 2016.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.